Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 5-hydroxytryptamine receptor 1D | ||
Ligand | BDBM50473511 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1743 (CHEMBL616948) | ||
IC50 | 2042±n/a nM | ||
Citation | Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. J Med Chem44:681-93 (2001) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
5-hydroxytryptamine receptor 1D | |||
Name: | 5-hydroxytryptamine receptor 1D | ||
Synonyms: | 5-HT-1D | 5-HT-1D-alpha | 5-HT1D | 5-hydroxytryptamine receptor 1D (5-HT1D) | 5HT1D_HUMAN | HTR1D | HTR1DA | HTRL | Serotonin (5-HT) receptor | Serotonin Receptor 1D | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 41920.63 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Receptor binding assays were performed using human clone stably expressed in CHO cells. | ||
Residue: | 377 | ||
Sequence: |
| ||
BDBM50473511 | |||
n/a | |||
Name | BDBM50473511 | ||
Synonyms: | CHEMBL159536 | ||
Type | Small organic molecule | ||
Emp. Form. | C18H23N5 | ||
Mol. Mass. | 309.4087 | ||
SMILES | CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Cc3n[nH]c(C)n3)cc12 |wU:5.7,wD:3.2,(17.25,-10.91,;15.75,-10.6,;14.73,-11.75,;15.26,-9.14,;15.96,-7.77,;14.59,-7.08,;13.89,-8.46,;14.1,-5.62,;15.01,-4.38,;14.08,-3.13,;12.63,-3.62,;11.29,-2.85,;9.96,-3.63,;9.96,-5.17,;8.62,-5.94,;8.62,-7.46,;9.88,-8.37,;9.4,-9.84,;7.86,-9.84,;6.95,-11.09,;7.39,-8.37,;11.29,-5.94,;12.63,-5.16,)| | ||
Structure |